Stockreport

Mirum Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update

Mirum Pharmaceuticals, Inc. - common stock  (MIRM) 
Last mirum pharmaceuticals, inc. - common stock earnings: 3/12 04:02 pm Check Earnings Report
PDF - Third quarter 2025 total revenue of $133 million- 2025 revenue guidance updated to $500 to $510 million- Phase 2b VISTAS topline data expected second quarter of 2026- [Read more]